Timing of the Second Varicella Vaccine Dose in Adults
Recommended Dosing Schedule
- Adults ≥ 13 years should receive the second dose of VARIVAX 4–8 weeks after the first dose, with a minimum acceptable interval of 4 weeks (28 days)【1】【2】.
- The standard interval of 4–8 weeks between doses is endorsed for this age group by the CDC’s Advisory Committee on Immunization Practices (ACIP)【2】【3】【4】.
- If more than 8 weeks have passed since the first dose, the second dose may be given without restarting the schedule【3】【4】.
Catch‑up Vaccination for Adults with Only One Prior Dose
- Adults who have received only a single prior dose should obtain a second catch‑up dose after a minimum interval of 4 weeks【3】【5】.
- The catch‑up dose may be administered at any interval longer than the 4‑week minimum, providing flexibility in scheduling【3】【6】.
Priority Groups for Timely Second Dose
- Healthcare personnel should be prioritized for completing the two‑dose series within the recommended interval【2】【4】【7】.
- Household contacts of immunocompromised individuals are also a priority group【4】【8】.
- Non‑pregnant women of childbearing age should receive the second dose on schedule to protect future pregnancies【4】【7】.
- College students and other institutional residents are recommended to complete the series promptly【4】【8】.
- International travelers should adhere to the 4–8 week interval to ensure protection before travel【4】【7】.
Post‑partum Vaccination Protocol
- For women lacking varicella immunity, the first dose should be administered before discharge after pregnancy completion or termination【3】【9】.
- The second dose should be given 4–8 weeks later, ideally coinciding with the routine postpartum visit at 6–8 weeks after delivery【3】【9】.
- Women are advised to avoid conception for at least 1 month after each vaccine dose【9】.
Contraindications Relevant to the Second Dose
- Severe immunocompromising conditions (e.g., advanced HIV, chemotherapy) contraindicate administration of the second dose【1】.
- HIV infection with CD4 count < 200 cells/µL is a specific contraindication for the second dose【1】.
Evidence Summary
- The ACIP and the 2020 Adult Immunization Schedule consistently recommend the 4–8 week interval for adults ≥ 13 years, citing immunogenicity data and practical implementation considerations【2】【4】【7】【8】.
Overall, the recommendation is a *strong, guideline‑based recommendation* (Level A) from the CDC’s ACIP, reflecting high‑quality evidence and expert consensus.